DOD Aims to Shield Warfighters From Novel Biological Agents
Jan. 10, 2023
The Department of Defense is modernizing its approach for developing medical countermeasures to protect warfighters from novel biological agents.
This is made clear in a new document, "Approach for Research, Development and Acquisition of Medical Countermeasures and Test Products," which was recently published by the Office of the Deputy Assistant Secretary of Defense for Chemical and Biological Defense. This office oversees the Department of Defense's Chemical and Biological Defense Program. The CBDP's mission is to anticipate future threats and deliver capabilities that enable the Joint Force to fight and win in CB-contested environments.
https://www.defense.gov/News/News-Stories/Article/Article/3261095/dod-aims-to-shield-warfighters-from-novel-biological-agents/
Chemical and Biological Defense Program
Approach for Research, Development,
and Acquisition of Medical
Countermeasure and Test Products
2022
UNCLASSIFIED
https://media.defense.gov/2023/Jan/10/2003142624/-1/-1/0/APPROACH-RDA-MCM-TEST-PRODUCTS.PDF